The FDA’s recent decision to classify Laboratory-Developed Tests (LDTs) as medical devices has had a profound impact on the industry. In the absence of any passed legislation in 2022, the…
Read More
Commencing January 1, 2023, pathologists across the healthcare landscape gained access to a valuable arsenal of 13 new digital pathology add-on codes. These codes represent a significant milestone, brought to…
